SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-002172
Filing Date
2022-02-28
Accepted
2022-02-28 08:30:44
Documents
12
Period of Report
2022-02-25
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20220225.htm   iXBRL 8-K 53630
  Complete submission text file 0000950170-22-002172.txt   172755

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20220225.xsd EX-101.SCH 2498
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20220225_lab.xml EX-101.LAB 13438
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20220225_pre.xml EX-101.PRE 9938
6 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20220225_htm.xml XML 4729
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 22684051
SIC: 2834 Pharmaceutical Preparations